| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,600,000 | 7,203,000 | 6,441,000 | 9,140,000 | | Cost of Revenue | 6,433,000 | 7,512,000 | 5,350,000 | 5,552,000 | | | Gross Profit | 2,167,000 | (309,000) | 1,091,000 | 3,588,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,106,000 | (455,000) | 816,000 | 2,925,000 | | Non Recurring | 511,000 | 69,000 | 79,000 | 229,000 | | Others | 124,000 | 144,000 | 125,000 | 134,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (574,000) | (67,000) | 71,000 | 300,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 73,000 | 22,000 |
-
| (26,000) | | Earnings Before Interest And Taxes | (501,000) | (45,000) | 71,000 | 274,000 | | Interest Expense | 3,000 | 49,000 | 21,000 | (11,000) | | Income Before Tax | (504,000) | (94,000) | 50,000 | 285,000 | | Income Tax Expense | (218,000) | (53,000) | (1,000) | 81,000 | | Minority Interest | (26,000) | (73,000) |
-
|
-
| | | | Net Income From Continuing Ops | (213,000) | (114,000) | 51,000 | 204,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 20,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (312,000) | (94,000) | 51,000 | 204,000 | | Preferred Stock And Other Adjustments |
-
| 39,000 | (39,000) |
-
| | | Net Income Applicable To Common Shares | ($312,000) | ($55,000) | $12,000 | $204,000 |
|
0.01% Nasdaq 
0.22%
Income Statement
